东方田鼠感染血清免疫筛选日本血吸虫成虫cDNA文库

东方田鼠 (Microtusfortis ,Mf)对日本血吸虫 (Schistosomajaponicum ,Sj)感染具有抗性 .为探讨Mf感染Sj后是否产生针对虫体某些特异抗原分子的免疫应答 ,用Mf感染血清对Sj成虫cDNA文库进行免疫筛选 .经初筛和复筛 ,共筛选出 12个阳性克隆 .这些阳性克隆经辅助噬菌体自动剪切后PCR扩增显示 ,插入的SjcDNA片段大小在 3 0 0bp至 1 8kb之间 ,其中 1 8kb片段 5个 ,1kb片段 1个 ,3 0 0bp片段6个 .经DNA测序分析 ,鉴定出 3个未曾报道过的Sj新基因 ,分别命名为Sj Mf1、Sj Mf2和Sj胞质氨基肽酶 ,并在GenBank登记注册 .结果说明 ,Mf感染血清可识别Sj的特异性抗原分子 ,这些抗原分子的免疫保护作用值得进一步研究 .     

用suc2信号肽捕获系统筛选小鼠胚胎cDNA文库基因

PCR扩增 1 1d小鼠胚胎cDNA文库插入片段 ,将 0 .5～ 2 0kb的扩增产物插入筛选载体的多克隆位点 ,转化suc2基因缺陷酵母宿主菌 .然后将约 1 0 5个酵母菌落接种于选择性平板上进行筛选 ,得到了 1 82个可在选择性培养基上生长的菌落 .PCR扩增显示 ,插入片段大小分布于 0 1～ 1 5kb之间 .对其中 1 4个阳性菌落的重组子进行序列测定 ,分别代表 6种不同的基因序列 ,与报告基因都有正确的读框内融合 .其中两种基因序列反复被筛到 ,分别命名为spt1、spt2 .spt1 [gi:2 772 876 6 ],可能以非编码RNA的身份参与蛋白质向细胞外分泌的过程 ,而spt2编码多个连续的赖氨酸 ,可能通过非经典途径介导蛋白质的分泌     

棉铃虫细胞色素P450 cDNA片段的克隆与序列分析

以 5龄实验室敏感品系棉铃虫Helicoverpaarmigera的总RNA为模板 ,采用简并性引物 ,利用反转录 -多聚酶链式反应 (RT PCR)扩增出了 2个新的长度分别为 2 3 7bp和 2 40bp的cDNA片段。序列分析表明 ,2 3 7bp的cDNA片段与棉铃虫P45 0CYP4家族有较高的相似性 ,最高达 73 %;而 2 40bp的cDNA片段与CYP6家族有较高的相似性 ,最高达 49%。     

利用mRNA差别显示技术分离盐胁迫下红树植物白骨壤耐盐相关cDNA

从福建龙海红树林自然保护区采集白骨壤的隐胎生果实 ,在实验室分别置于 0‰盐度海水和 50‰盐度海水进行沙培。分别取叶片 ,提取纯化RNA。通过锚定引物OligodT₁₂ GC反转录和 8个 10核苷酸随机引物进行PCR扩增 ,经 8%非变性聚丙烯酰胺凝胶电泳后发现了 3个差异DNA片段只在高盐培养条件的白骨壤基因组中表达 ,而在无盐培养条件中没有出现。这 3个差异cDNA片段分别命名为csrg1(600bp)、csrg2(550bp)、csrg3(480bp)。3个差异cDNA片段的RNA杂交结果显示 ,只有csrg1片段存在明显差异 高盐中有杂交斑点 ,无盐中无杂交斑点 ;而其余 2个片段在高盐和无盐条件下都没有杂交斑点出现。从而表明csrg1就是耐盐相关cDNA。进一步将csrg1片段克隆 ,并进行DNA序列分析。全序列在GenBank中查询后 ,未发现相关同源片段。耐盐相关cDNA片段的获得 ,将为分离全长耐盐基因 ,搞清该基因表达调控的机理提供条件.     

核苷酸切除修复基因XPA反义RNA表达载体的构建及其抑瘤功能

采用RT PCR方法扩增出 4 2 6bp着色性干皮病A(xerodermapigmentosumgroupA ,XPA)cDNA片段 (2～ 4 2 7bp) ,反向插入pcDNA3 1质粒构建XPA反义RNA表达载体 .经测序证实 ,该片段序列与XPAmRNA对应片段完全互补 .通过脂质体Lipofectamine 2 0 0 0将重组质粒转染肺癌A5 4 9细胞 ,RT PCR检测表明转染XPA反义RNA重组质粒能够抑制肺癌细胞XPAmRNA表达 ;MTT实验表明转染XPA反义RNA的肺癌细胞对顺铂敏感性增强 .本研究为深入探讨NER途径基因功能及临床克服肿瘤耐药提出了一个新的思路     

应用引物延伸预扩增提高微量DNA拷贝数

采用引物延伸预扩增方法 ,可普遍提高微量模板DNA的拷贝数 ,便于进行基因分析时克服标本量少、来源困难的制约。采用常规扩增、检测 2 4 8bp的DYZ1片段体系为观察对象 ,其最小模板量需 1.5ng/2 0 μl体系。以 15个碱基随机寡核苷酸为引物 ,对最小模板量进行预扩增 ,再以其产物 1/10为模板 ,特异扩增DYZ1片段。进行相对定量分析 ,判断原模板DNA拷贝数增加的程度。结果 1.5ng男性DNA经随机扩增后 ,此DYZ1片段拷贝数增加了 10倍以上 ,大大地提高了特异DNA片段扩增的模板量。表明经随机引物延伸预扩增后 ,微量标本DNA片段拷贝数获得普遍提高 ,增加了微量DNA扩增的敏感度     

复合PCR扩增人mtDNA HVR方法的初探

目的:建立一种高效的扩增线粒体DNA高可变区(mtDNA HVR)的方法.方法:本研究选取5例健康成人静脉血,用人血全基因组DNA试剂盒,提取全基因组DNA,设计引物,用复合PCR方式,对线粒体DNA中的高可变区进行扩增.复合扩增的方式为:用6对套叠引物分开进行两次独立的PCR,扩增mtDNA HVR.第一次扩增用3对引物,目标DNA片段基本涵盖整个线粒体DNA的高可变区,扩增后得到互不重叠的3个短片段,分别为113 bp,126 bp和131bp.第二次复合扩增用其余的3对引物,目标片段基本重叠在第一次扩增所得的目标片段的区域内,扩增得到3个互不重叠的片段为124 bp,133 bp和93bp.所有扩增产物经过纯化后测序.结果:复合PCR方式获得的mtDNA HVR基因序列完整,5个样本均出现特异性条带,电泳结果条带单一、清晰.结论:复合扩增PCR方法对mtDNA HVR区的扩增效率高,测序结果稳定,结合6对套叠引物,不但保证了序列的完整性,另外,两次独立的PCR也减少了PCR反应过程中错配的发生,此法也适用于保存时间较久的古代线粒体DNA短片段的研究.复合扩增PCR还展示出了潜在的高产量的特点,相对传统PCR显示了其更多的优势.     

间隔子修饰引物对扩增产物电泳行为的作用初探

目的:初步研究利用C3Spacer间隔子修饰引物对扩增产物电泳行为的影响及作用。方法:选取1个常用短串联重复序列(STR)位点,利用间隔子修饰该位点荧光标记引物,以DNA标准物质为模板进行PCR扩增,记录相应扩增产物DNA片段长度,进行修饰与长度变化的相关性分析。结果:选取STR位点D13S317,分别利用TTTTC3SpacerC3Spacer、TTTTC3Spacer、TTTT修饰R0X标记引物,相应扩增产物长度为182.67±0.05、182.19±0.11和181.6±0.19bp,未进行修饰的对照组引物扩增产物长度为177.09±0.15 bp,产物DNA片段长度随不同修饰基团的修饰发生规律性变化。结论:发现了一种修饰基团,用该基团修饰引物后,可在体外通过PCR反应改变扩增产物等位基因片段的大小,从而在不改变特异性引物信息的前提下使产物发生规律性位移,修饰基团与DNA片段大小呈内在相关性。     

登革热病毒基因组末端cDNA的克隆及序列分析

采用磁性分离技术从登革热病毒(D2-04株)感染的C6/36细胞中分离了D2-04病毒RNA.以该RNA为模板进行RT-PCR,分别扩增了D2-04 RNA 5′和3′端cDNA片段,该cDNA片段分别克隆到pGEM-3Z质粒多聚接头的HincⅡ位点得到含有5′端284 bp及3′端525 bp cDNA的重组质粒.通过荧光标记引物及双脱氧核苷酸PCR方法测定了上述cDNA插入片段的序列.同源性比较结果证明D2-04株与其他不同株间的同源性较高,可达93%～98%;不同型间的同源性较差, 仅80%左右; 属间的同源性更低.     

大鼠肝和BERH—2肝癌5Kb BamHI DNA片段的克隆及其转录研究

本文克隆了大鼠肝和肝癌BERH-2 DNA的分子大小约为5kb的BamHI片段(Bam5族重复顺序)。从筛选出的克隆中取一个来自肝癌细胞基因组DNA的克隆片段H5 B-1和来自肝细胞基因组DNA克隆片段L5 B-4做进一步分析研究。采用RNA点杂交法对L5 B-4DNA片段的转录产物在细胞核、质间分布的研究结果表明:L5 B-4 DNA片段转录产物在肝癌细胞的总核RNA,poly A~ 核RNA和poly A~-核RNA中的相对量,比正常肝细胞的相应RNA组分低;在肝癌细胞的总胞质RNA和多聚核蛋白体RNA中的相对量,则比正常肝细胞的相应RNA组分高;其转录产物在poly A~ 核RNA中的相对含量高于其他细胞RNA组分,几乎不存在于rRNA中。当用大鼠肝和肝癌总RNA进行RNA点杂交比较时其转录产物在肝癌细胞中的相对含量则高于正常肝。结果提示,L5 B-4 DNA片段的转录产物从细胞核向细胞质内转运,肝癌细胞明显高于正常肝细胞。以H5 B-1 DNA片段代替L5 B-4 DNA片段进行RNA点杂交,得近似的杂交放射自显影图谱。     

Isolation of a small DNA fragment carrying the gene for a dihydrofolate reductase from a trimethoprim resistance factor

Summary DNA fragments of the R factor R388 which renders E. coli resistant to trimethoprim by inducing a trimethoprim resistant dihydrofolate reductase (Amyes and Smith, 1974) were inserted into plasmids and screened for the expression of the trimethoprim resistance gene. By means of a two step deletion procedure a 1770 bp EcoRI/BamH1 fragment was isolated which conferred drug resistance and which was found to induce the synthesis of the same dihydrofolate reductase as the parental R factor. Gene dosage experiments indicated that the induction was due to the presence of a dihydrofolate reductase structural gene on the 1770 bp fragment. The gene could be assigned to a segment which was less than 1200 bp long. The 1770 bp fragment and a recombinant plasmid consisting of pSF2124 and part of R388 were mapped with several restriction nucleases. The R factor induced enzyme was partially purified from a strain carrying a multicopy recombinant plasmid into which the 1770 bp fragment was inserted and which induced high levels of dihydrofolate reductase. The enzyme was found to be stable at 100°. Some aspects of the synthesis of dihydrofolate reductase are discussed.Dedicated to Professor Peter Karlson on the occasion of his 60th birthday     

Low level of mitochondrial deoxyguanosine kinase is the dominant factor in acquired resistance to 9-beta-D-arabinofuranosylguanine cytotoxicity

9-beta-D-arabinofuranosylguanine (Ara-G) is an important and relatively new guanosiue analog with activity in patients with T-cell malignancies. The biochemical and molecular events leading to resistance to Ara-G are not fully understood. Therefore we generated two Ara-G-resistant human MOLT-4 leukemic cell lines with different levels of resistance. The mitochondrial enzyme deoxyguanosine kinase (dGK) and the nuclear/cytosol enzyme deoxycytidine kinase (dCK) are key enzymes in the activation of Ara-G. Decreased levels of dGK protein and mRNA were found in both resistant cell sublines. The activity of dCK was decreased in the subline with higher resistance to Ara-G and these cells were highly cross-resistant to other nucleosides activated by dCK. Increased activity of the mitochondrial enzyme thymidine kinase 2 was observed in both resistant sublines and this could be related to the dGK deficiency. In search for other resistance mechanisms it was found that the resistant cells overexpress the mdr1 gene, while no changes were detected in the levels of multidrug resistance-associated protein 1 through 6, lung resistance-associated protein or topoisomerase IIalpha or IIbeta. Taken together, our findings demonstrate that multiple mechanisms are involved in the acquired resistance to Ara-G. However, low expression of dGK is the most apparent alteration in both resistant cell lines. Partial deficiency of dCK was found in the subline cells with higher resistance to Ara-G. Furthermore, Ara-G may select for high expression of the multidrug resistance (mdr1) which could be a specific resistance mechanism but more likely part of an overall cellular stress response.     

Potential of ribozymes against deoxycytidine kinase to confer drug resistance to cytosine nucleoside analogs

Hematopoietic toxicity is the dose-limiting side effect produced in cancer chemotherapy with deoxycytidine nucleoside analogs. Deletion of the deoxycytidine kinase (dCK), results in a drug resistance phenotype to these analogs. An interesting gene therapy strategy to confer drug resistance to cytosine nucleoside analogs would be to specifically inactivate the dCK in normal hematopoietic stem cell. In this study, we designed hammerhead ribozymes that can specifically cut and downregulate the murine dCK mRNA. Three different ribozymes were identified and shown to cleave in vitro the dCK RNA. After introduction of ribozyme cDNA into murine L1210 leukemic cells by retroviral transfer, two of the ribozymes showed some capacity in reducing dCK activity. However, analysis of transduced L1210 clones showed that the significant reduction in the dCK mRNA was not sufficient to confer drug resistance to cytosine arabinoside. Nevertheless, these results provide a new avenue of modulating the dCK enzyme activity and with improved modifications may have the potential for use in gene therapy to confer drug resistance to deoxycytidine analogs.     

Cytotoxic activity of 2',2'-difluorodeoxycytidine, 5-aza-2'-deoxycytidine and cytosine arabinoside in cells transduced with deoxycytidine kinase gene

Deoxycytidine nucleoside analogs must be first phosphorylated to become active anticancer drugs. The rate-limiting enzyme in this pathway is deoxycytidine kinase (dCK). Cells deficient in this enzyme are resistant to these analogs. To evaluate the potential of dCK to be used as suicide gene for deoxycytidine nucleoside analogs, we transduced both human A-549 lung carcinoma and murine NIH3T3 fibroblast cell lines with this gene. The dCK-transduced cells showed an increase in cytotoxicity to the analogs, cytosine arabinoside (ARA-C), and 5-aza-2'-deoxycytidine (5-AZA-CdR). Unexpectedly, the related analog, 2',2'-difluorodeoxycytidine (dFdC), was less cytotoxic to the dCK-transduced cells than the wild-type cells. For the A-549-dCK cells, the phosphorylation of dFdC by dCK was much greater than control cells. In accord with the elevated enzyme activity, we observed a 6-fold increased dFdC incorporation into DNA and a more pronounced inhibition of DNA synthesis in the A-549-dCK cells. In an attempt to clarify the mechanism of dFdC, we investigated its action on A549 and 3T3 cells transduced with both cytidine deaminase (CD) and dCK. We reported previously that overexpression of CD confers drug resistance to deoxycytidine analogs. In this study, when the CD-transduced cells were also transduced with dCK they became relatively more sensitive to dFdC. In addition, we observed that dFdU, the deaminated form of dFdC, was cytotoxic to the A-549-dCK cells, but not the wild-type cells. Our working hypothesis to explain these results is that the mitochondrial thymidine kinase (TK2), an enzyme reported to phosphorylate dFdC, acts as an important modulator of dFdC-induced cell toxicity. These findings may further clarify the action of dFdC and the mechanism by which it induces cell death.     

利用多重PCR反应同时筛选番茄Cf-9和Tm-1基因

利用同一PCR反应体系,对分别与番茄抗叶霉病的Cf-9基因和抗番茄烟草花叶病毒病的Tm-1基因紧密连锁的PCR标记进行了同时扩增筛选,扩增的特异性片段与单引物扩增片段吻合。其中与Cf-9基因紧密连锁的CAPs标记在抗感试材均可扩增出560bp的特异片段,且都存在TaqⅠ酶切位点,抗病基因型酶切后分别产生了450bp、330bp和290bp的不同特异性片段,而感病基因型试材酶切后产生450bp和290bp的特异性片段;与Tm-1基因紧密连锁的SCAR标记为显性标记,只有抗病试材产生750bp的特异片段,不能被TaqⅠ酶切。经反复验证,结果稳定准确,可用于在同一PCR反应体系中对两个抗病基因进行同时筛选鉴定。该体系的建立不仅省时、省工、节省费用,而且可用于苗期辅助选育,加快番茄抗病育种进程。     

Molecular characterization of mutation associated with rifampicin and isoniazid resistance in Mycobacterium tuberculosis isolates

Nucleotide changes in catalase peroxidase (Kat G) gene and gene encoding the beta subunit of RNA polymerase (rpo B), responsible for isoniazid and rifampicin drug resistance were determined in the clinical isolates of Mycobacterium tuberculosis by PCR-RFLP, Line probe assay and DNA sequencing. PCR-RFLP test was performed by HapII cleavage of an amplified fragment of Kat G gene to detect the transversion 315AGC-->ACC(Ser-->Thr) which is associated with INH drug resistance. The Line probe assay kit was evaluated to detect the mutation in 81bp RMP resistance determining region of rpo B gene associated with RMP drug resistance. These results were validated by DNA sequencing and drug susceptibility test. Kat G S 315 T mutation was found in 74.19% strains of M. tuberculosis from Delhi. This mutation was not found in any of the susceptible strains tested. The line probe assay kit and DNA sequencing identified 18 isolates as RMP resistant with specific mutation, while one of the RMP resistant strain was identified as RMP susceptible, with a concordance of 94.73% with the phenotypic drug susceptibility result. Majority (8 of 19, 42.1%) of resistant isolates involved base changes at codon 531 of rpo B gene. Both PCR-RFLP and Line probe assay test can be used in many of the clinical microbiology laboratories for early detection of isoniazid and rifampicin drug resistance in clinical isolates of M. tuberculosis.     

Three short fragments of Rts1 DNA are responsible for the temperature-sensitive growth phenotype (Tsg) of host bacteria.

Rts1 is a multiphenotype drug resistance factor, and one of its phenotypes is temperature-sensitive growth (Tsg) of host bacteria. A 3.65-kb fragment from Rts1 DNA was shown to cause the Tsg phenotype in host cells. This tsg fragment was split by a restriction enzyme, HincII, into four fragments. Two of these fragments were called HincII-S (short) and HincII-L (long), respectively. Each of these two fragments conferred the Tsg phenotype, indicating that, in fact, these two independent regions were responsible for the Tsg phenotype. The HincII-S 783-bp and HincII-L 1,479-bp fragments were sequenced. The region in the HincII-S fragment to which the Tsg phenotype was attributed was narrowed to a 146-bp (nucleotides 1 to 146) fragment by various restriction enzyme digestions. Further digestion of the 146-bp fragment with Bal 31 suggested that the 116-bp (nucleotides 9 to 124) fragment is the minimum sequence required for Tsg. On the other hand, in the HincII-L fragment, a fragment of 249 bp (nucleotides 1210 to 1458) and a fragment of 321 bp (nucleotides 1942 to 2262) contained separate temperature-sensitive growth activity. None of three tsg fragments contained open reading frames. The 249-bp fragment had very weak Tsg activity, while the 321-bp fragment had no Tsg activity. On the other hand, when these two fragments were together in the pUC19 vector, they exhibited very strong Tsg activity equivalent to that of the original 1,479-bp fragment. In addition, two of the 249-bp fragments gave similar, strong Tsg activity. The HincII-L 1,479-bp fragment contained an open reading frame for kanamycin resistance which was found between nucleotides 1423 and 2238. This kanamycin resistance gene sequence was different from that of the reported kanamycin resistance gene of Tn903 at 12 positions which were deduced to change seven amino acids.     

一株污水源多重耐药大肠杆菌的耐药性检测及全基因组测序分析

【背景】水体环境分布广、流动性强,是耐药菌和耐药基因传播的主要媒介。【目的】了解北方污水厂大肠杆菌携带的耐药基因及可移动遗传元件情况。【方法】从北方污水厂筛选出一株多重耐药大肠杆菌,通过药敏试验进行耐药性检验,采用96孔板法测定菌株的最小抑菌浓度,利用酶标仪探究亚抑菌浓度抗生素对菌株生长的影响,并对菌株进行全基因组测序,对其携带的耐药基因及可移动遗传元件进行预测。【结果】大肠杆菌WEC对四环素、环丙沙星、诺氟沙星和红霉素具有耐药性,亚抑菌浓度的四环素、环丙沙星和诺氟沙星能够延缓或抑制菌株的生长。WEC菌株的基因组中包含一条大小为4 782 114 bp的环状染色体和2个大小分别为60 306 bp (pWEC-1)和92 065 bp (pWEC-2)的环状质粒。菌株共携带129个耐药基因,其中128个位于染色体上,在染色体上预测到原噬菌体、基因岛及插入序列的存在,部分可移动遗传元件携带有耐药基因。质粒pWEC-1中无耐药基因,pWEC-2含有1个耐药基因,在质粒基因组中预测到原噬菌体和插入序列。【结论】污水源大肠杆菌WEC是一株多重耐药菌株,其基因组中携带耐药基因和多种可移动遗传元件...     

Plasmidial maintenance in rodent fibroblasts of a BPV1-pBR322 shuttle vector without immediately apparent oncogenic transformation of the recipient cells.

A recombinant plasmid was constructed (pV69) which comprises a subgenomic fragment of bovine papilloma virus type 1 (BPV1) DNA, part of plasmid pBR322 DNA and a drug resistance gene expressed in both mammalian fibroblasts and Escherichia coli. This gene (vv2) is a modified form of the bacterial neomycin resistance gene (neo) linked to the herpes simplex virus thymidine kinase (tk) promoter (plasmid pAG60), to which the original bacterial neo promoter from transposon Tn5 was added back, upstream of the eukaryotic promoter. It induced kanamycin resistance in E. coli, as well as resistance to the drug G418 in rat and mouse fibroblasts. Its expression in FR3T3 rat cells was enhanced as compared with the original tk-neo construction. After transfer of plasmid pV69 into C127 mouse cells or FR3T3 rat cells, the number of resistant colonies selected in medium containing G418 was one to two orders of magnitude higher than that of transformed foci in normal medium. In eight independent cell lines selected by drug resistance, pV69 DNA was found to be maintained in a plasmidial state, without any detectable rearrangement or deletion and could be transferred back in E. coli. In contrast, cell lines selected by focus formation in normal medium maintained deleted forms of the original plasmid DNA, and only part of them were resistant to G418. Most of the drug-resistant clones had kept the morphology and growth control of the normal fibroblasts. However, with further passages in culture, these cells spontaneously produced transformed foci with increasing frequencies.